Skip to main content

Foundation Medicine: Brian Alexander

Foundation Medicine announced that Brian Alexander, the company's chief medical officer, would take over as CEO for Cindy Perettie. Perettie has taken on a new role at Roche Diagnostics, the company said.

Alexander joined FMI as senior VP of clinical development in 2018 and was promoted to CMO in 2019. As CMO, Alexander has expanded the company's molecular tumor board program and launched a genomics and health disparities effort, the company said.

Alexander has served as a radiation oncologist at the Dana-Farber Cancer Institute and Brigham and Women's Cancer Center and an associate professor at Harvard Medical School. He is an affiliated researcher at the Massachusetts Institute of Technology's Laboratory for Financial Engineering and affiliated faculty at the Harvard Kennedy School Healthcare Policy Program. 

He was the founding director of the Program in Regulatory Science at Dana-Farber and the Harvard/MIT Center for Regulatory Science. He also cofounded the nonprofit Global Coalition for Adaptive Research and served as a White House fellow and special assistant to the Secretary of Veterans Affairs.  

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.